
AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent
Global biopharmaceutical company Ascentage Pharma, specialising in haematological malignancies, has presented results from five preclinical studies at the American Association of Cancer Research (AACR) 2025 annual meeting. Ascentage – which is engaged in …